Integrative Molecular Characterization of Malignant Pleural Mesothelioma
Open accessPublished version of a preprint
The DOI matches its Crossref record; 61 of the 62 references it cites were found in a registry or an index.
Abstract
Abstract Malignant pleural mesothelioma (MPM) is a highly lethal cancer of the lining of the chest cavity. To expand our understanding of MPM, we conducted a comprehensive integrated genomic study, including the most detailed analysis of BAP1 alterations to date. We identified histology-independent molecular prognostic subsets, and defined a novel genomic subtype with TP53 and SETDB1 mutations and extensive loss of heterozygosity. We also report strong expression of the immune-checkpoint gene VISTA in epithelioid MPM, strikingly higher than in other solid cancers, with implications for the immune response to MPM and for its immunotherapy. Our findings highlight new avenues for further investigation of MPM biology and novel therapeutic options. Significance: Through a comprehensive integrated genomic study of 74 MPMs, we provide a deeper understanding of histology-independent determinants of aggressive behavior, define a novel genomic subtype with TP53 and SETDB1 mutations and extensive loss of heterozygosity, and discovered strong expression of the immune-checkpoint gene VISTA in epithelioid MPM. See related commentary by Aggarwal and Albelda, p. 1508. This article is highlighted in the In This Issue feature, p. 1494
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Furthermore, a study that explored 74 mesothelioma tumors using a genomic analysis identified TGF-β1 mRNA expression as being correlated with the worst patient prognoses [40].”
From Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma (2023) · cites this paper as [40]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
Bindea, G., Mlecnik, B., Tosolini, M., Kirilovsky, A., Waldner, M., Obenauf, A. C., Angell, H., Fredriksen, T., Lafontaine, L., Berger, A., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.10.003 · Cited by 4,422
Absolute quantification of somatic DNA alterations in human cancer
Carter, S. L., Cibulskis, K., Helman, E., McKenna, A., Shen, H., Zack, T., Laird, P. W., Onofrio, R. C., Winckler, W., Weir, B. A., et al. (2012) · Nature Biotechnology · doi:10.1038/nbt.2203 · Cited by 2,053
Self-citationThe Life History of 21 Breast Cancers
Nik-Zainal, S., Van Loo, P., Wedge, D. C., Alexandrov, L. B., Greenman, C. D., Lau, K. W., Raine, K., Jones, D., Marshall, J., Ramakrishna, M., et al. (2012) · Cell · doi:10.1016/j.cell.2012.04.023 · Cited by 1,443 · cited 1×
“Since MPM with evidence of GNH have typically undergone a genome-doubling event, we were able to assess the timing of this relative to point mutations (30,31).”
BackgroundSelf-citationSomatic mutation in cancer and normal cells
Martincorena, I., & Campbell, P. J. (2015) · Science · doi:10.1126/science.aab4082 · Cited by 1,396 · cited 1×
“This places MPM at the low end of somatic mutation burden among cancers (8).”
BackgroundSelf-citationShen, R., & Seshan, V. E. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw520 · Cited by 1,258
Self-citationBroz, M. L., Binnewies, M., Boldajipour, B., Nelson, A. E., Pollack, J. L., Erle, D. J., Barczak, A., Rosenblum, M. D., Daud, A., Barber, D. L., et al. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.09.007 · Cited by 1,207
Clock-like mutational processes in human somatic cells
Alexandrov, L. B., Jones, P. H., Wedge, D. C., Sale, J. E., Campbell, P. J., Nik-Zainal, S., & Stratton, M. R. (2015) · Nature Genetics · doi:10.1038/ng.3441 · Cited by 1,058
Self-citationBueno, R., Stawiski, E. W., Goldstein, L. D., Durinck, S., De Rienzo, A., Modrusan, Z., Gnad, F., Nguyen, T. T., Jaiswal, B. S., Chirieac, L. R., et al. (2016) · Nature Genetics · doi:10.1038/ng.3520 · Cited by 919
Self-citationShen, R., Olshen, A. B., & Ladanyi, M. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp543 · Cited by 849 · cited 1×
“To find out whether multi-platform molecular profiling might provide additional resolution to define prognostic subsets of MPM, we performed integrative clustering across multiple assay platforms using two algorithms: iCluster (32) and PARADIGM (33).”
MethodSelf-citationVaske, C. J., Benz, S. C., Sanborn, J. Z., Earl, D., Szeto, C., Zhu, J., Haussler, D., & Stuart, J. M. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq182 · Cited by 786
Self-citation
Cited by
Items 401–500 of 675
Rosati, D., Maurizi, B. G., Serio, V. B., Maffeo, D., Rina, A., Mari, F., Palmieri, M., Giordano, A., & Frullanti, E. (2025) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2025.104973 · Cited by 5
Parikh, K., Hendriks, L. E. L., Bironzo, P., & Remón, J. (2021) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2021.102250 · Cited by 5
Mesothelioma Mouse Models with Mixed Genomic States of Chromosome and Microsatellite Instability
Song, Y., Baxter, S. S., Dai, L., Sanders, C., Burkett, S. S., Baugher, R. N., Mellott, S. D., Young, T. B., Lawhorn, H. E., Difilippantonio, S., et al. (2022) · Cancers · doi:10.3390/cancers14133108 · Cited by 5
de Miguel‐Pérez, D., Pickering, E. M., Malapelle, U., Grier, W. R., Pepe, F., Pisapia, P., Russo, G., Pinto, J. A., Russo, A., Troncone, G., et al. (2023) · European Journal of Cancer · doi:10.1016/j.ejca.2023.113457 · Cited by 5
Clonal gene signatures predict prognosis in mesothelioma and lung adenocarcinoma
Lin, Y., Burt, B. M., Lee, H., Nguyen, T. T., Jang, H.-J., Lee, C., Hong, W., Ripley, R. T., Amos, C. I., & Cheng, C. (2024) · npj Precision Oncology · doi:10.1038/s41698-024-00531-y · Cited by 5
Malignant pleural mesothelioma: The disdained member of thoracic oncology!
Khosla, D., Singh, P. K., Chhabria, B. A., Kataria, V., Singh, N., & Kapoor, R. K. (2024) · World Journal of Experimental Medicine · doi:10.5493/wjem.v14.i3.91739 · Cited by 5
Xu, D., Liang, S., Su, M., Yang, H., Bruggmann, R., Oberhaensli, S., Zhang, Y., Gao, Y., Marti, T. M., Wang, W., et al. (2024) · Lung Cancer · doi:10.1016/j.lungcan.2024.107986 · Cited by 5
Ad-SGE-DKK3 Gene Therapy Overcomes Resistance to Immune Checkpoint Blockade in Pleural Mesothelioma
Jang, H.-J., Patel, M., Wang, D. Y., Kang, S. W., Choi, J. M., Lee, C., Vilchis, M., Shim, J. S., Mitra, S., Ranchod, P., et al. (2025) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-24-4024 · Cited by 5
Assié, J., Meiller, C., Stern, E., Lasvergnas, J., Arnould, M., Pan, L., Montagne, F., Sequeiros, R., Zreibi, C. A., Nery, E. D., et al. (2025) · Cancer Research · doi:10.1158/0008-5472.can-24-3822 · Cited by 5
The Rocky Road from Preclinical Findings to Successful Targeted Therapy in Pleural Mesothelioma
Paajanen, J., Bueno, R., & Rienzo, A. D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113422 · Cited by 5
Self-citationPromising therapeutic potential of tumor suppressor microRNAs for malignant pleural mesothelioma
Dixit, S., Choi, A., Singh, A. N., Pittala, K., Pruett, N. D., & Hoang, C. D. (2022) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2022.70 · Cited by 5
Martínez-Fernández, C., Jha, S., Aliagas, E., Holmberg, C. I., Nadal, E., & Cerón, J. (2023) · Cells · doi:10.3390/cells12060929 · Cited by 5
Vannucchi, M., Pennati, V., Mencaroni, C., Defraia, C., Bardhi, L., Castiglione, F., Bellan, C., & Comin, C. (2023) · Cancers · doi:10.3390/cancers15072072 · Cited by 5
Singh, A. N., Pruett, N. D., Dixit, S., Gara, S. K., Wang, H., Pahwa, R., Schrump, D. S., & Hoang, C. D. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02889-6 · Cited by 5
Therapeutic Strategies to Improve the Treatment of Pleural Mesothelioma
Mirra, L., Beretta, G. L., Lisini, D., Marcianti, A., Spampinato, E., Corno, C., Costantino, M., Corsico, A. G., Stella, G. M., & Perego, P. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673268206240405084558 · Cited by 5
van Kooten, J. P., Dietz, M. V., Dubbink, H. J., Verhoef, C. K., Aerts, J. G. J. V., Madsen, E. V. E., & von der Thüsen, J. H. (2024) · Clinical and Experimental Medicine · doi:10.1007/s10238-024-01342-y · Cited by 5
Offin, M. D., Sauter, J. L., Tischfield, S. E., Egger, J. V., Chavan, S. S., Shah, N., Manoj, P., Ventura, K., Allaj, V., de Stanchina, E., et al. (2022) · Genome Medicine · doi:10.1186/s13073-022-01129-4 · Cited by 5
Self-citationNew Markers for Management of Mesothelioma
Nash, A., Firth, T., & Creaney, J. (2023) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0043-1769097 · Cited by 5
Self-citationXia, H., Feng, L., Lin, L., Jiang, Z., Chen, J., Shi, W., Ying, S., Yu, M., Ju, L., Zhu, L., et al. (2020) · Environmental Research · doi:10.1016/j.envres.2020.110467 · Cited by 5
Myeloid Cell Mobilization and Recruitment by Human Mesothelioma in NSG-SGM3 Mice
Shindyapin, V. V., Gubernatorova, E. O., Gorshkova, E. A., Chicherina, N. R., Sysonov, F. A., Yakovleva, A. S., Bogdanova, D. A., Demidov, O. N., Samsonova, M. V., Baklaushev, V. P., et al. (2024) · Cells · doi:10.3390/cells13242135 · Cited by 4
Liu, B., Yu, T., Ren, R., Wu, N., Xing, N., Wang, J., Wu, W., Cao, X., & Zhang, J. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-024-10383-3 · Cited by 4
Self-citationAdvances in the relationship of immune checkpoint inhibitors and DNA damage repair
Liu, X., Wang, S., Lv, H., Chen, E., Yan, L., & Yu, J. (2025) · Current Research in Translational Medicine · doi:10.1016/j.retram.2025.103494 · Cited by 4
Intra-clustering analysis reveals tissue-specific mutational patterns
Choudalakis, S., Kastis, G. A., & Δικαίος, Ν. (2025) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2025.108681 · Cited by 4
Transcriptional landscape of pleural mesothelioma patients in relation to NF2 gene mutational status
Orozco, C. A., Mejía‐García, A., Tsao, H. M., Bonilla, D. A., Carvajal-Fierro, C., Brugés-Maya, R., Cómbita, A. L., & Parra-Medina, R. S. (2025) · Journal of the Egyptian National Cancer Institute · doi:10.1186/s43046-025-00284-0 · Cited by 4
Yang, S., Hao, Y., Wang, K., Xu, H., Huang, L., Xu, L., Meng, R., Li, B., Huang, J., Zhu, Y., et al. (2025) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359251378879 · Cited by 4
Carbone, M., Amos, C. I., Attanoos, R. L., Boeri, M., Bueno, R., Bunn, P. A., Chirieac, L. R., Cooper, B. T., Fennell, D. A., Galateau-Sallé, F., et al. (2026) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2025.11.002 · Cited by 5
Self-citationClinical Importance of Molecular Biomarkers in Pleural Mesothelioma
Roof, L., Koehler, K., & Verschraegen, C. F. (2026) · Cancers · doi:10.3390/cancers18040679 · Cited by 4
Gibson, V., Działo, J., Messier, T., Bzura, A., Poile, C., Rogel, J., Hahne, J. C., Habibovic, A., Stead, S., Saaman, A., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-75153-y · Cited by 4
Kang, J., Zhang, Z., Zhang, R., Zheng, M., Jiang, C., Yang, H., Tong, A., & Zhang, Y. (2024) · MedComm – Oncology · doi:10.1002/mog2.78 · Cited by 4
Current drug therapy for pleural mesothelioma
Imai, H. (2025) · Respiratory Investigation · doi:10.1016/j.resinv.2024.12.017 · Cited by 4
Zhu, L., Ying, S., Su, X., Yu, W., Yan, K., Shen, W., Hu, S., Jiang, Z., Xia, H., Feng, L., et al. (2025) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2025.118357 · Cited by 4
Tenhaken, V., Seternes, O. M., Cascorbi, I., & Bruckmueller, H. (2025) · BMC Cancer · doi:10.1186/s12885-025-14434-z · Cited by 4
Cerbone, L., Orecchia, S., Bertino, P., Delfanti, S., Angelis, A. M. D., & Grosso, F. (2023) · Cancers · doi:10.3390/cancers15245716 · Cited by 4
Pagliuca, F., Lucà, S., SIO, M. D., Arcaniolo, D., Facchini, G., Martino, M. D., Esposito, F., Vita, F. D., Chieffi, P., & Franco, R. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.155069 · Cited by 4
Malignant peritoneal mesothelioma interactome with 417 novel protein–protein interactions
Karunakaran, K. B., & Ganapathiraju, M. K. (2024) · BJC Reports · doi:10.1038/s44276-024-00062-w · Cited by 4
Yamaguchi, R., & Perkins, G. A. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-35727-6_2 · Cited by 4
RNA editing in mesothelioma: a look forward
Hariharan, A., Sun, S., Wipplinger, M., & Felley‐Bosco, E. (2020) · Open Biology · doi:10.1098/rsob.200112 · Cited by 4
Accelerating innovations in systemic therapy for pleural mesothelioma
Fennell, D. A., & Bzura, A. (2022) · Nature Cancer · doi:10.1038/s43018-022-00419-5 · Cited by 4
Malignant and borderline mesothelial tumors of the pleura
Chapel, D. B., Vivero, M., & Sholl, L. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-79547-0.00030-8 · Cited by 4
BAP1 Loss Predicts Therapeutic Vulnerability in Malignant Peritoneal MesotheliomaPreprint
Shrestha, R., Nabavi, N., Lin, Y.-Y., Mo, F., Anderson, S., Volik, S., Adomat, H. H., Lin, D., Xue, H., Dong, X., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/243477 · Cited by 4
Editorial: Emerging Therapies for Malignant Mesothelioma
van Zandwijk, N., Reid, G., & Baas, P. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00939 · Cited by 4
Self-citationRevisiting “BAP1ness” in Malignant Pleural Mesothelioma
Yang, H., Yao, F., & Peng, R. (2022) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2022.04.014 · Cited by 4
Mesothelioma survival prediction based on a six-gene transcriptomic signature
Behrouzfar, K., Mutsaers, S. E., Chin, W. L., Patrick, K., Ng, I. T., Pixley, F. J., Morahan, G., Lake, R., & Fisher, S. A. (2024) · iScience · doi:10.1016/j.isci.2024.111011 · Cited by 3
Digital spatial profiling for pathologists
Donati, B., Manzotti, G., Torricelli, F., Ascione, C., Valli, R., Santandrea, G., Ragazzi, M., Zanetti, E., Ciarrocchi, A., & Piana, S. (2024) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-024-03955-w · Cited by 3
Artificial intelligence and machine learning in thoracic surgery- A scoping review
Kutywayo, K. H., Chandarana, K., Das, I., & Rathinam, S. (2025) · Clinical Surgical Oncology · doi:10.1016/j.cson.2025.100086 · Cited by 3
van Genugten, J. H. L. T., Faulkner, D., Hahne, J. C., Poile, C., Wessels, L. F. A., Fennell, D. A., & Baas, P. (2025) · Lung Cancer · doi:10.1016/j.lungcan.2025.108769 · Cited by 3
Seyedshahi, F., Rakovic, K., Poulain, N., Quiros, A. C., Powley, I. R., Richards, C. J., Uraiby, H., Klebe, S., Moore, D. A., Nakas, A., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-63846-9 · Cited by 3
Intratumour, anatomical and temporal heterogeneity in mesothelioma
Arnould, M., Neilly, M. D. J., Blyth, K. G., & Jean, D. (2025) · Thorax · doi:10.1136/thorax-2024-222052 · Cited by 3
Pleural Mesothelioma Diagnosis for the Pulmonologist: Steps Along the Way
Fantin, A., Castaldo, N., Crisafulli, E., Sartori, G., Patrucco, F., Grosu, H. B., Vailati, P., Morana, G., Patruno, V., Kette, S., et al. (2025) · Cancers · doi:10.3390/cancers17233866 · Cited by 3
Sato, T., Hasegawa, I., Ikeda, H., Ohshiro, T., Kondo‐Ida, L., Mukai, S., Ohte, S., Maeda, T., & Sekido, Y. (2025) · Cancers · doi:10.3390/cancers17243983 · Cited by 3
Self-citationMoving Beyond Morphology: Toward a Morpho-Molecular Classification of Pleural Mesothelioma
Drevet, G., Kalson, L., Mangé, L., Galateau-Sallé, F., Scherpereel, A., Chalabreysse, L., Mazières, J., Brčić, L., Alcala, N., Maury, J., et al. (2026) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2026.01.003 · Cited by 3
Self-citationYang, S., Tjota, M. Y., Goren, E., Giroux, D. J., Galateau-Sallé, F., Husain, A. N., Kindler, H. L., Drazer, M. W., Aly, R. G., Dycoco, J., et al. (2026) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2026.103681 · Cited by 3
Self-citationCalabrò, L., Caruso, F. P., Covre, A., Noviello, T., Lofiego, M. F., Tufano, R., Ferraro, L., Grisolia, P., Falco, A. D., Lagano, V., et al. (2026) · Nature Genetics · doi:10.1038/s41588-026-02580-4 · Cited by 3
Mesothelioma: is chemotherapy alone a thing of the past?
Bibby, A. C., Blyth, K. G., Sterman, D. H., & Scherpereel, A. (2020) · European Respiratory Society eBooks · doi:10.1183/2312508x.10024219 · Cited by 3
Offin, M. D., Fitzgerald, B. G., Zauderer, M. G., & Doroshow, D. B. (2023) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2022.140 · Cited by 3
Self-citationIbstedt, S., Piccinelli, P., Sydow, S., Koster, J. D., & Mertens, F. (2024) · Genes Chromosomes and Cancer · doi:10.1002/gcc.23255 · Cited by 3
Umegaki, T., Moriizumi, H., Ogushi, F., Takekawa, M., & Suzuki, T. (2024) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1012536 · Cited by 3
Orfanoudaki, M., Shaikh, A. F., Wang, D., Singh, V., Du, L., Wilson, J. A., Wamiru, A., Goncharova, E. I., Pruett, N. D., Hoang, C. D., et al. (2025) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5c00786 · Cited by 3
Cedrés, S., Serna, G., González‐Medina, A., Valdivia, A., Assaf-Pastrana, J. D., Iranzo, P., Callejo, A., Pardo, N., Navarro, A., Martínez‐Martí, A., et al. (2023) · Cancers · doi:10.3390/cancers15143611 · Cited by 3
Pleural Mesothelioma: Treatable Traits of a Heterogeneous Disease
Bertuccio, F. R., Agustoni, F., Galli, G., Bortolotto, C., Saddi, J., Baietto, G., Baio, N., Montini, S., Putignano, P., D’Ambrosio, G., et al. (2023) · Cancers · doi:10.3390/cancers15245731 · Cited by 3
Targeted Therapy in Mesotheliomas: Uphill All the Way
Bertoli, E., Carlo, E. D., Bortolot, M., Stanzione, B., Conte, A. D., Spina, M., & Bearz, A. (2024) · Cancers · doi:10.3390/cancers16111971 · Cited by 3
Advances towards potential cancer therapeutics targeting Hippo signaling
Zhu, R., Jiao, Z., & Yu, F. (2024) · Biochemical Society Transactions · doi:10.1042/bst20240244 · Cited by 3
Hedgehog Signaling in Mesothelioma: 2019 Status
Felley‐Bosco, E. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.01121 · Cited by 3
Unusual Histology in Mesothelioma: A Report of Two Cases with a Brief Review
Bono, F., Ceola, S., Beretta, C., & Jaconi, M. (2022) · Diagnostics · doi:10.3390/diagnostics12020371 · Cited by 3
Offin, M. D., Rusch, V. W., Rimner, A., Adusumilli, P. S., & Zauderer, M. G. (2022) · The Oncologist · doi:10.1093/oncolo/oyac113 · Cited by 3
Self-citationAstoul, P. J. (2020) · Translational Lung Cancer Research · doi:10.21037/tlcr-20-592 · Cited by 3
Social Disparities in Thoracic Surgery Database Research
Mitchell, K. G., Bostock, I. C., & Antonoff, M. B. (2021) · Thoracic surgery clinics/Thorac. surg. clin. · doi:10.1016/j.thorsurg.2021.09.007 · Cited by 3
Napoli, F., Rapa, I., Izzo, S., Rigutto, A., Libener, R., Riganti, C., Bironzo, P., Taulli, R., Papotti, M. G., Volante, M., et al. (2022) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-022-03321-8 · Cited by 3
Reply to: Oncolytic Viral Therapy for Malignant Pleural Mesothelioma
Jean, D., Delaunay, T., Meiller, C., Boisgerault, N., G�rard, M., Caruso, S., Blanquart, C., Felley‐Bosco, E., Bennouna, J., Tangy, F., et al. (2020) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2020.04.011 · Cited by 3
Mejía‐García, A., Bonilla, D. A., Ramirez, C. M., Díaz, F. A. E., Cómbita, A. L., Forero, D. A., & Orozco, C. A. (2023) · Biochemical Genetics · doi:10.1007/s10528-023-10426-5 · Cited by 2
Mesothelioma: molecular pathology and biomarkers
Hung, Y. P. (2024) · Die Pathologie · doi:10.1007/s00292-024-01344-3 · Cited by 2
Qiao, Y., Zhu, S., Liu, Z., Kelley, N., Zheng, Z., Fletcher, J. A., & Ou, W. (2025) · Cancer Gene Therapy · doi:10.1038/s41417-025-00904-w · Cited by 2
Self-citationClinicopathologic Characteristics and Clinical Outcomes of Patients with Testicular Mesothelioma
Agrawal, P., Baky, F., Sarungbam, J., Sheinfeld, J., Reuter, V. E., Cercek, A., Nash, G. M., Sauter, J. L., Travis, W. D., Simone, C. B., et al. (2025) · Annals of Surgical Oncology · doi:10.1245/s10434-025-17978-3 · Cited by 2
Self-citationLi, J., He, H., Zhang, Y., Azhar, M. S., & Wang, Y. (2025) · Clinical and Experimental Medicine · doi:10.1007/s10238-025-01949-9 · Cited by 2
Delsignore, M., Cassinari, G., Revello, S., Cerbone, L., Grosso, F., Arsura, M., & Porta, C. (2025) · Cancers · doi:10.3390/cancers17244020 · Cited by 2
Immunotherapy advances in pleural mesothelioma
Zhang, A. L., & Hsu, M. L. (2026) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359261420028 · Cited by 2
Ramundo, V., Palazzo, M. L., Lignola, S., Raimondo, D., Kopecka, J., & Aldieri, E. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27052157 · Cited by 2
Hu, H. X., Li, L., Bian, W., & Wu, X. (2026) · Discover Oncology · doi:10.1007/s12672-026-04725-7 · Cited by 2
The genetics of cancer heterogeneity and mesothelioma
Chirieac, L. R., Gill, R., & Attanoos, R. L. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1744382 · Cited by 2
Self-citationUpdate on Pleural Epithelioid Mesothelioma: New Insights for Diagnosis and Patient Management
Galateau-Sallé, F., Beasley, M. B., Brčić, L., Cooper, W., Dacic, S., de Perrot, M. E., Tsao, M., Klebe, S., Churg, A., Mansfield, A. S., et al. (2026) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2026.103720 · Cited by 2
Self-citationEinarsson, H., Sukov, W. R., Molligan, J., & Folpe, A. L. (2026) · Modern Pathology · doi:10.1016/j.modpat.2026.100999 · Cited by 2
Cai, Y.-X., Liu, S.-J., Sun, Q., Li, H., & Meng, X.-L. (2026) · Cardiology Research and Practice · doi:10.1155/crp/5272035 · Cited by 2
Self-citationTargeting key epigenetic regulators in solid tumors: focus on EZH2, PRMT5, and BET inhibitors
Sánchez, I. H. D. C., Ruidiaz, M. A., Moreno, V., Long, H. W., & Cejas, P. (2026) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2026.103145 · Cited by 2
López-Lago, M. A., Taleb, M., Ningoo, M., Okada, T., Li, X., Lee, H.-S., Burt, B. M., Offin, M. D., Chintala, N. K., & Adusumilli, P. S. (2026) · Med · doi:10.1016/j.medj.2026.101149 · Cited by 2
Küçüköner, M., Demir, T., Alsubaie, A. M., Alabalık, U., Ibrahim, A. K., Pierobon, M., & Liotta, L. A. (2026) · Current Oncology Reports · doi:10.1007/s11912-026-01754-x · Cited by 2
Mesothelioma: Pleural, Version 3.2026, NCCN Clinical Practice Guidelines In Oncology
Stevenson, J., Riely, G. J., Wood, D. E., Aisner, D. L., Axtell, A. L., Bauman, J. R., Bharat, A., Chang, J. Y., Desai, A. P., Dilling, T. J., et al. (2026) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2026.0038 · Cited by 3
Self-citationIn vitro and in vivo laboratory models of pleural disease
Yao, X., & Kanellakis, N. I. (2020) · European Respiratory Society eBooks · doi:10.1183/2312508x.10032719 · Cited by 2
Aksoy, A., Tektemur, A., Melek, E., Kayfeci, M., Uslu, M. F., Cosar, U., & Etem, E. Ö. (2020) · Współczesna Onkologia · doi:10.5114/wo.2020.102826 · Cited by 2
Jaurand, M., Meiller, C., & Jean, D. (2021) · Respiratory disease series · doi:10.1007/978-981-15-9158-7_2 · Cited by 2
Felley‐Bosco, E. (2021) · Precision Cancer Medicine · doi:10.21037/pcm-21-4 · Cited by 2
Johnson, B., Lee, K. M. L., & Cheng, Y. Y. (2021) · Onco · doi:10.3390/onco1020006 · Cited by 2
A Novel Two-Gene Expression-Based Prognostic Score in Malignant Pleural Mesothelioma
Shivarov, V. S., Blazhev, G., & Yordanov, A. D. (2023) · Diagnostics · doi:10.3390/diagnostics13091556 · Cited by 2
Cerbone, L., Rio, B. D., Delfanti, S., Boccuzzi, F., Barbieri, P., Angelis, A. M. D., Meda, S., Savi, L., Righi, L., Sculco, M., et al. (2024) · Lung Cancer Management · doi:10.1080/17581966.2024.2424133 · Cited by 2
Chrissian, A. A., Abbas, H., Chaddha, U., Debiane, L. G., DeBiasi, E. M., Filsoof, D., Hashmi, M. D., Morton, C., Naselsky, W., Pannu, J. K., et al. (2024) · Journal of Bronchology & Interventional Pulmonology · doi:10.1097/lbr.0000000000000999 · Cited by 2
Emerging Drug Therapies for Mesothelioma
Oien, D. B., CHIEN, J. R., Molina, J. R., & Shridhar, V. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.91752 · Cited by 2
Dozin, B., Carbotti, G., Roncella, S., Ferro, P., Dessanti, P., Canessa, P. A., Ferrini, S., & Fabbi, M. (2021) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-021-02965-w · Cited by 2
Wang, Z., Yang, H., Luo, B., Duan, P., & Lin, P. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.805256 · Cited by 2
Self-citationMesothelioma: Hippo pathway as a target, lessons from COMMAND
Fennell, D. A., & Baitei, E. Y. (2019) · Oncotarget · doi:10.18632/oncotarget.27018 · Cited by 2
Commentary: Tasting individual ingredients of meso soup: Can 'omics bring out the flavor?
Pass, H. I. (2020) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2020.03.149 · Cited by 2
Self-citationCommentary: A chess game for mesothelioma treatment: Not checkmate yet!
Pass, H. I. (2022) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2022.02.003 · Cited by 2
Self-citation
Metadata
- Authors
- Hmeljak, J., Sanchez-Vega, F., Hoadley, K. A., Shih, J., Stewart, C., Heiman, D., Tarpey, P., Danilova, L., Drill, E., Gibb, E. A., Bowlby, R., Kanchi, R., Osmanbeyoglu, H. U., Sekido, Y., Takeshita, J., Newton, Y., Graim, K., Gupta, M., Gay, C. M., Diao, L., Gibbs, D. L., Thorsson, V., Iype, L., Kantheti, H., Severson, D. T., Ravegnini, G., Desmeules, P., Jungbluth, A. A., Travis, W. D., Dacic, S., Chirieac, L. R., Galateau-Sallé, F., Fujimoto, J., Husain, A. N., Silveira, H. C., Rusch, V. W., Rintoul, R. C., Pass, H., Kindler, H., Zauderer, M. G., Kwiatkowski, D. J., Bueno, R., Tsao, A. S., Creaney, J., Lichtenberg, T., Leraas, K., Bowen, J., TCGA Research Network, Felau, I., Zenklusen, J. C., Akbani, R., Cherniack, A. D., Byers, L. A., Noble, M. S., Fletcher, J. A., Robertson, A. G., Shen, R., Aburatani, H., Robinson, B. W., Campbell, P., Ladanyi, M., Aburatani, H., Akbani, R., Ally, A., Anur, P., Armenia, J., Auman, J. T., Balasundaram, M., Balu, S., Baylin, S. B., Becich, M., Behrens, C., Beroukhim, R., Bielski, C., Bodenheimer, T., Bootwalla, M. S., Bowen, J., Bowlby, R., Brooks, D., Bueno, R., Byers, L. A., Cárcano, F. M., Carlsen, R., Carvalho, A. L., Cherniack, A. D., Cheung, D., Chirieac, L., Cho, J., Chuah, E., Chudamani, S., Cibulskis, C., Cope, L., Crain, D., Creaney, J., Curley, E., Dacic, S., Danilova, L., Rienzo, A. D., DeFreitas, T., Demchok, J. A., Dhalla, N., Dhir, R., Diao, L., Drill, E., Felau, I., Feldman, M., Ferguson, M. L., Fletcher, J. A., Fujimoto, J., Fujimoto, J., Fukuda, S., Gabriel, S. B., Sallé, F. G., Gao, J., Gardner, J., Gastier-Foster, J. M., Gay, C. M., Gehlenborg, N., Gerken, M., Getz, G., Gibb, E. A., Gibbs, D. L., Goparaju, C., Graim, K., Gross, B., Guo, G., Gupta, M., Hasegawa, S., Haussler, D., Hayes, D. N., Heiman, D. I., Heins, Z., Hmeljak, J., Hoadley, K. A., Holt, R. A., Hoyle, A. P., Husain, A., Hutter, C. M., Iype, L., Jefferys, S. R., Jones, S. J. M., Jones, C. D., Kanchi, R. S., Kasaian, K., Kim, J., Kindler, H., Kondo, N., Krausz, T., Kundra, R., Kuribayashi, K., Kwiatkowski, D. J., Ladanyi, M., Lai, P. H., Laird, P. W., Lawrence, M. S., Lee, D., Leraas, K. M., Lichtenberg, T. M., Lin, P., Liu, J., Liu, W., Liu, E. M., Lolla, L., Longatto-Filho, A., Lu, Y., Luketich, J., Ma, Y., Maglinte, D. T., Mallory, D., Marra, M. A., Mayo, M., Meier, S., Melamed, J., Meng, S., Meyerson, M., Mieczkowski, P. A., Mills, G. B., Moore, R. A., Moran, C., Morris, S., Mose, L. E., Mungall, A. J., Mungall, K., Nakano, T., Naresh, R., Newton, Y., Noble, M. S., Ochoa, A., Osmanbeyoglu, H., Parker, J. S., Pass, H. I., Paulauskis, J., Pennathur, A., Pennell, N. A., Penny, R., Perou, C. M., Pihl, T., Ramirez, N. C., Rassl, D. M., Ravegnini, G., Reid, G., Reis, R. M., Reynolds, S. M., Rice, D., Richards, W. G., Rintoul, R. C., Roach, J., Robertson, A. G., Rusch, V., Sadeghi, S., Saksena, G., Sanchez-Vega, F., Sander, C., Sato, A., Scapulatempo-Neto, C., Schein, J. E., Schultz, N., Schumacher, S. E., Seiwert, T., Sekido, Y., Severson, D. T., Shelton, C., Shelton, T., Shen, R., Sheridan, R., Shi, Y., Shih, J., Shiraishi, Y., Shmulevich, I., Silveira, H. C. S., Simons, J. V., Sipahimalani, P., Skelly, T., Sofia, H. J., Soloway, M. G., Spellman, P., Stewart, C., Stuart, J., Sun, Q., Takeshita, J., Tam, A., Tan, D., Tarnuzzer, R., Tatsuno, K., Taylor, B. S., Thiessen, N., Thompson, E., Thorsson, V., Travis, W. D., Tsao, A., Tse, K., Tsujimura, T., Valdivieso, F., Van Den Berg, D. J., van Zandwijk, N., Veluvolu, U., Viana, L. S., Voet, D., Wan, Y., Wang, Z., Wang, J., Weaver, J., Weinstein, J. N., Weisenberger, D. J., Wilkerson, M. D., Wise, L., Wistuba, I., Wong, T., Wu, Y., Yamamoto, S., Yang, L., Zauderer, M. G., Zenklusen, J. C., Zhang, J., Zhang, H., Zhang, H., & Zmuda, E.
- Affiliations
- 3Department of Genetics, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
- Wellcome Sanger Institute (GB)
- 10Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
- 11Computational Systems Biology, Memorial Sloan Kettering Cancer Center, New York, New York.
- The University of Texas at Dallas (US)
- Institut universitaire de cardiologie et de pneumologie de Québec (CA)
- Memorial Sloan Kettering Cancer Center (US)
- 23Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
- 24MESOPATH. Cancer Center Leon Berard, Lyon, France.
- 26Department of Pathology, University of Chicago, Chicago, Illinois.
- 27Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Sao Paulo, Brazil.
- 28Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
- 30Department of Cardiothoracic Surgery, NYU Langone Medical Center, New York, New York.
- 15Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
- 35The Research Institute at Nationwide Children's Hospital, Columbus, Ohio.
- 36National Cancer Institute, Bethesda, Maryland.
- 18Division of Thoracic Surgery, The Lung Center and International Mesothelioma Program, Brigham and Women's Hospital, Boston, Massachusetts.
- The University of Western Australia (AU)
- ORCID
- Tarpey, Patrick
- Kantheti, Havish
- Desmeules, Patrice
- Jungbluth, Achim A.
- Silveira, Henrique C.
- Tsao, Anne S.
- Robinson, Bruce W.
- Campbell, Peter
- Armenia, Joshua
- Auman, J. Todd
- Baylin, Stephen B.
- Becich, Michael
- Behrens, Carmen
- Beroukhim, Rameen
- Bootwalla, Moiz S.
- Cibulskis, Carrie
- Cope, Leslie
- Rienzo, Assunta De
- Dhir, Rajiv
- Ferguson, Martin L.
- Fukuda, Shiro
- Gabriel, Stacey B.
- Gao, Jianjiong
- Gehlenborg, Nils
- Getz, Gad
- Goparaju, Chandra
- Gross, Benjamin
- Guo, Guangwu
- Hasegawa, Seiki
- Haussler, David
- Hayes, D. Neil
- Heins, Zachary
- Holt, Robert A.
- Hoyle, Alan P.
- Jefferys, Stuart R.
- Jones, Steven J.M.
- Jones, Corbin D.
- Kasaian, Katayoon
- Kim, Jaegil
- Kondo, Nobuyuki
- Kundra, Ritika
- Kuribayashi, Kozo
- Laird, Peter W.
- Lawrence, Michael S.
- Lee, Darlene
- Lin, Pei
- Liu, Jia
- Liu, Wenbin
- Liu, Eric Minwei
- Lu, Yiling
- Luketich, James
- Maglinte, Dennis T.
- Marra, Marco A.
- Mayo, Michael
- Melamed, Jonathan
- Meyerson, Matthew
- Mieczkowski, Piotr A.
- Mills, Gordon B.
- Mungall, Andrew J.
- Nakano, Takashi
- Ochoa, Angelica
- Parker, Joel S.
- Pennathur, Arjun
- Pennell, Nathan A.
- Perou, Charles M.
- Pihl, Todd
- Ramirez, Nilsa C.
- Rassl, Doris M.
- Reid, Glen
- Reis, Rui M.
- Rice, David
- Richards, William G
- Roach, Jeffrey
- Sadeghi, Sara
- Saksena, Gordon
- Sander, Chris
- Sato, Ayuko
- Schultz, Nikolaus
- Schumacher, Steven E.
- Seiwert, Tanguy
- Shi, Yan
- Shiraishi, Yuichi
- Sofia, Heidi J.
- Spellman, Paul
- Sun, Qiang
- Tam, Angela
- Tarnuzzer, Roy
- Tatsuno, Kenji
- Taylor, Barry S
- Tsujimura, Tohru
- Wang, Jing
- Weaver, Joellen
- Weinstein, John N.
- Weisenberger, Daniel J.
- Wilkerson, Matthew D.
- Wistuba, Ignacio
- Wong, Tina
- Wu, Ye
- Yamamoto, Shogo
- Yang, Liming
- Zhang, Jiashan
- Zhang, Hailei
- Zhang, Hongxin
- Zmuda, Erik
- Venue
- Cancer Discovery
- Published
- 2018-12-01
- Volume
- 8
- Issue
- 12
- Pages
- 1548-1565
- ISSN
- 2159-8274 (ISSN-L)
- 2159-8290
- PMC
- PMC6310008
- OpenAlex
- W2897299514
- Cited by
- 618
- References
- 62
- Citations by year
- 2026: 53 · 2025: 62 · 2024: 61 · 2023: 78 · 2022: 96 · 2021: 117 · 2020: 100 · 2019: 45 · 2018: 4
- FWCI
- 50.06
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cancer Discovery (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion, other-oa)
- Funders
- HHS | National Institutes of Health (NIH) (U54 HG003273, U24 CA143858, U24 CA143866, U24 CA143867, U24 CA143882, U24 CA143883, U24 CA144025, P30 CA016672, P30 CA008748, U54 HG003067, U54 HG003079, U24 CA143799, U24 CA143835, U24 CA143840, U24 CA143843, U24 CA143845, U24 CA143848)
- British Lung Foundation (BLF) (APG11-7)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Health Sciences › Medicine › Surgery › Intraperitoneal and Appendiceal Malignancies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- malignant pleural mesothelioma, TP53 mutation, loss of heterozygosity, genomic subtypes, VISTA, immune checkpoint, epithelioid mesothelioma, immunotherapy, antitumor immunity
- MeSH terms
- Aged, Female, Humans, Lung Neoplasms, Male, Mesothelioma, Middle Aged, Mutation, Pleural Neoplasms, Prognosis, Histone-Lysine N-Methyltransferase, Protein Methyltransferases, Biomarkers, Tumor, Tumor Suppressor Proteins, Ubiquitin Thiolesterase, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.